Blend Labs Inc SEC Filings

Form 144 filing for Blend Labs, Inc. (BLND) reports a proposed sale of 25,000 common shares to be executed through Charles Schwab & Co., Inc. on 08/15/2025 with an aggregate market value of $71,873. The shares were acquired on 02/17/2020 via exercise and hold and fully paid in cash.

The filer previously sold a total of 150,000 shares in six transactions between 06/16/2025 and 07/15/2025, generating aggregate gross proceeds of $503,272. The issuer's reported outstanding shares are 255,696,747, and the planned sale is recorded on the NYSE.

Amendment No. 2 to a Schedule 13G reports current beneficial ownership of Blend Labs, Inc. Class A common stock by several 8VC-related entities and by Joe Lonsdale. The filing shows 8VC Co-Invest LP holds 6,897,728 shares (2.7%) with shared voting and dispositive power, and Opportunities II holds 4,975,791 shares (2.0%) with shared voting and dispositive power. Joe Lonsdale is reported to beneficially own 11,873,519 shares (4.7%) with sole voting and dispositive power over that aggregate amount.

Percentages are calculated on a base of 254,775,978 shares outstanding as of April 30, 2025, as cited in the filing. The reporting persons disclaim beneficial ownership except to the extent of pecuniary interest, and the filing states it only amends the items specified in this Amendment while leaving other previously reported items unchanged.

Winnie Ling, Head of Legal and People at Blend Labs, reported a sale of 4,000 shares of Class A common stock on 08/07/2025. The sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025. The filing reports a weighted average sale price of $3.6192 per share, with sale prices ranging from $3.61 to $3.645 per share and notes that a breakdown of shares sold at each price is available on request.

Following the reported transaction Ling directly beneficially owns 372,018 shares. The disposal reduced her pre-sale direct holding by roughly 1.06%, consistent with a modest, preplanned disposition under an established trading plan rather than an ad hoc sale.

Blend Labs (BLND) Q2-25 10-Q highlights:

• Revenue rose 9.9% YoY to $31.5 m; software platform revenue grew 11.0% to $29.4 m, while services slipped 4.0% to $2.1 m.
• Gross margin expanded to 74.0% (vs. 70.9%), lifting gross profit to $23.3 m (+14.6%).
• Cost discipline: R&D -43%, Sales & Marketing -23%, offset by G&A +20%; total opex fell 16% to $27.9 m.
• Operating loss narrowed sharply to $(4.6) m from $(13.1) m; net loss attributable to common holders improved to $(11.0) m, or $(0.04)/share, vs. $(23.6) m, $(0.09).
• Six-month view: revenue +11% to $58.3 m; net loss cut 61% to $(25.7) m.
• Cash & equivalents $36.5 m; marketable securities $51.8 m, giving liquidity of $88.3 m. Operating cash flow turned positive at +$14.8 m (vs. -$6.3 m LY).
• Balance sheet: stockholders’ equity improves to $(22.6) m from $(56.4) m, helped by reclassifying the Title365 non-controlling interest to equity and lower deficit. Deferred revenue jumped to $32.7 m (from $19.2 m), signaling larger future delivery obligations.
• Capital structure: 260.1 m shares outstanding (Class A/B); 150k Series A preferred now carries $150.2 m redemption value, with $4.4 m quarterly accretion; warrant for 11.1 m Class A shares unexercised.
• Strategic actions: Title business classified as discontinued; Q2 discontinued loss $(3.0) m. Minority buy-out ended put option, removing $52 m mezzanine liability.

Outlook: Management stresses cost control and liquidity; no formal guidance provided.